Package Leaflet: Information for the User
Ebastina Quasset 20 mg Oral Disintegrating Tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
even if they have the same symptoms as you, as it may harm them.
a side effect not listed in this package leaflet. See section 4.
Contents of the Package Leaflet
Ebastina Quasset belongs to a group of medications called antihistamines (antiallergics).
Ebastina Quasset is indicated for the treatment of symptoms of allergic processes such as seasonal or perennial allergic rhinitis, with or without allergic conjunctivitis (such as nasal discharge, nasal itching, eye itching, tearing, sneezing), chronic urticaria, and allergic dermatitis.
Do not takeEbastina Quasset
Warnings and Precautions
Consult your doctor or pharmacist before starting to take Ebastina Quasset.
This medication should be used with caution:
Do not use this medication if you have an acute allergic emergency, as ebastine (the active ingredient in this medication) takes 1 to 3 hours to take effect.
Children
Taking Ebastina Quasset with other medications
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
The following medications may interfere with ebastine; in these cases, it may be necessary to change the dose or interrupt treatment with one of them:
No interactions have been described between ebastine and theophylline, warfarin, cimetidine, diazepam, and alcohol.
Interference with Diagnostic Tests
Ebastina Quasset may interfere with the results of skin allergy tests, so it is recommended not to perform them until 5-7 days after treatment has been discontinued.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
There is no experience in pregnant women, so it is recommended to consult with a doctor before taking ebastine. The doctor will decide whether or not to start treatment.
Breastfeeding
It is unknown whether the medication passes into breast milk, so it should not be used during breastfeeding.
In humans, no effects have been observed on psychomotor function or the ability to drive or operate machinery at the recommended therapeutic doses. However, since drowsiness and dizziness are among the side effects, observe your response to treatment before driving or operating machinery.
Ebastina Quasset Oral Disintegrating Tablets contain aspartame (E-951)
This medication may be harmful to people with phenylketonuria because it contains aspartame, which is a source of phenylalanine.
Ebastina Quasset Oral Disintegrating Tablets containlactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist again.
Remember to take your medication.
Your doctor will indicate the duration of your treatment with ebastine.
Dosage
Use in Adults and Children Over 12 Years
The recommended dose is 10 mg of ebastine once a day, although some people may require a dose of 20 mg once a day.
Use in Patients with Severe Liver Disease
Do not exceed the dose of 10 mg of ebastine per day. In this case, it is recommended to use the 10 mg presentation.
Method of Administration
This medication is for oral administration.
If You Take More Ebastina Quasset Than You Should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20 (indicating the medication and the amount ingested) or go to the nearest hospital. Bring the remaining oral lyophilizates, the case, and the complete box so that the healthcare staff can more easily identify the medication you have taken.
Treatment of poisoning with this medication consists of gastric lavage and administration of the appropriate medication. Bring this package leaflet with you.
If You Forget to Take Ebastina Quasset
Do not take a double dose to make up for forgotten doses. Take the forgotten dose as soon as you remember and then continue taking this medication with your usual schedule. However, if it is almost time for your next dose, do not take the forgotten dose and wait for your next scheduled dose.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
The following side effects have been observed in clinical trials and post-marketing experience:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Rare (may affect up to 1 in 1,000 people):
Frequency Not Known(cannot be estimated from available data):
-Weight gain
-Increased appetite
Reporting Side Effects
If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date shown on the box after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medication in the pharmacy's SIGRE collection point. If you have any doubts, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition of Ebastina Quasset:
Appearance of the Product and Package Contents
Ebastina Quasset 20 mg is presented in the form of white, round oral disintegrating tablets with a diameter of 9 mm, packaged in blisters.
Package size: 20 oral disintegrating tablets.
Marketing Authorization Holder and Manufacturer:
Marketing Authorization Holder:
Industria Química y Farmacéutica VIR, S.A.
C/ Laguna 66-70, Polígono Industrial URTINSA II
28923 Alcorcón (Madrid)
Spain
Manufacturer:
SEID, S.A.
Carretera de Sabadell a Granollers Km 15
08185 Lliçà de Vall – Barcelona
Spain
Date of the Last Revision of this Package Leaflet:September 2020
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/